QQ客服 官方微博 反馈留言

	A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy.
	Lu, ZZ; Long, Y; Cun, XL; Wang, XH; Li, JP; Mei, L; Yang, YL; Li, M; Zhang, ZR; He, Q
刊名	Nanoscale
	2018
ISSN号	2040-3372
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1843801
专题	四川大学
作者单位	Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, 17,Block 3,Southern Renmin Rd, Chengdu 610041, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Lu, ZZ,Long, Y,Cun, XL,et al. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy.[J]. Nanoscale,2018.
APA	Lu, ZZ.,Long, Y.,Cun, XL.,Wang, XH.,Li, JP.,...&He, Q.(2018).A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy..Nanoscale.
MLA	Lu, ZZ,et al."A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy.".Nanoscale (2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。